Clinical trials (12 756)

Go to page

assignment

person_addRecruitingIPhase I

Phase 1/2 Open‑Label Study of VS‑7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and Combination Therapy in Patients with Advanced KRAS G12D‑Mutant Solid Tumors

A Coruna Galicia, Spain

Countries

Interventions

Carboplatin

Sponsors

Verastem Inc.

assignment

scheduleNot Yet RecruitingIIPhase II

Phase IIb Randomized Double‑Blind Placebo‑Controlled Dose‑Finding Study of Subcutaneous GIA632 in Adults with Moderate‑to‑Severe Cutaneous Lichen Planus

Bordeaux, France

Countries

Interventions

GIA632

Sponsors

Novartis Pharma AG

assignment

scheduleNot Yet RecruitingIIIPhase III

Inclisiran Added to Ezetimibe/Statin Therapy Reduces LDL‑C and Coronary Plaque Burden in Chronic Coronary Syndrome/Prior MI: 12‑Month Photon‑Counting CT Study

Milan, Italy

Countries

Interventions

Inclisiran

Sponsors

Policlinico San Donato S.p.A.

assignment

scheduleNot Yet RecruitingIIIPhase III

Randomized Multicenter Trial of Sublingual Sufentanil Versus Oral Morphine for Rescue Analgesia and Health Recovery on Post‑operative Day 3 in Surgical Patients

Reims, France

Countries

Interventions

Morphine Sulfate

Sponsors

Les Hopitaux Universitaires De Strasbourg

assignment

scheduleNot Yet RecruitingIIPhase II

Phase II Randomized Trial of Topical Papaverine to Prevent Vasospasm and Reduce Transient Hypoparathyroidism after Total Thyroidectomy in Adults

Countries

Interventions

Papaverine hydrochloride

Sponsors

Azienda Provinciale Per I Servizi Sanitari

assignment

scheduleNot Yet RecruitingIIPhase II

Phase 2 Trial of Oral Vemurafenib plus Venetoclax Followed by MRD‑Guided Rituximab in Relapsed/Refractory Hairy Cell Leukemia

Perugia, Italy

Countries

Interventions

Rituximab

Sponsors

Azienda Ospedaliera Di Perugia

assignment

scheduleNot Yet RecruitingIIIPhase III

Intranasal Oxytocin for Reducing Self‑Perceived Stress and Repetitive Behaviours in Adults with Autism Spectrum Disorder: A Randomized, Multicentre, Parallel‑Group Trial

Geel, Belgium

Countries

Interventions

Oxytocin

Sponsors

UZ Leuven

assignment

scheduleNot Yet RecruitingIIIPhase III

Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Rezpegaldesleukin (NKTR‑358) Monotherapy in Patients ≥12 Years with Moderate‑to‑Severe Atopic Dermatitis

Alicante, Spain

Countries

Interventions

Rezpegaldesleukin

Sponsors

Nektar Therapeutics

assignment

scheduleNot Yet RecruitingIIIPhase III

Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of Subcutaneous Rezpegaldesleukin (NKTR‑358) in Patients ≥12 Years with Moderate‑to‑Severe Atopic Dermatitis

Almada, Portugal

Countries

Interventions

Rezpegaldesleukin

Sponsors

Nektar Therapeutics

assignment

scheduleNot Yet RecruitingIPhase I

Phase 1 First‑in‑Human Randomized Double‑Blind Study of Intranasal Outer Membrane Vesicle–Based Pneumococcal Vaccine Ab-01.12 in Healthy Adults 18–49 Years

Nijmegen, The Netherlands

Countries

Sponsors

Radboud universitair medisch centrum Stichting

assignment

scheduleNot Yet RecruitingIIPhase II

Randomized Double‑Blind Placebo‑Controlled Study of Teverelix, a GnRH Antagonist, on Prostate Volume and Urinary Function in Men after First Acute Urinary Retention

Benesov, Czechia

Countries

Interventions

Teverelix

Sponsors

Antev Limited

assignment

scheduleNot Yet RecruitingIIIPhase III

Shortened postoperative antibiotic regimen (3 vs 5 days) in pediatric acute perforated appendicitis: non‑inferiority of piperacillin/tazobactam‑based combination therapy

Borås, Sweden

Countries

Interventions

Amoxicillin

Sponsors

Vaestra Goetalandsregionen

assignment

scheduleNot Yet RecruitingIPhase I

Safety and Pharmacokinetics of a Single Intravenous Dose of EuBAT as an Antidote in Healthy Adults: Randomized, Double‑Blind, Placebo‑Controlled Single‑Center Study

Gieres, France

Countries

Sponsors

Fabentech

assignment

scheduleNot Yet RecruitingIPhase I

Phase I/II Trial of MK-1568 in Patients with Prostate Cancer

Amsterdam, The Netherlands

Countries

Sponsors

Merck Sharp & Dohme LLC

assignment

scheduleNot Yet RecruitingIPhase I

Randomized Crossover Study Comparing Pharmacokinetics and Tolerability of Two Oral Liquid Formulations of Cannabidiol (CBD) in Healthy Adult Volunteers

Gieres, France

Countries

Sponsors

Cardiol Therapeutics Inc.

Go to page

Looking for deeper trial context?

Investigator involvement, centre context, regional background — we can pull it together.

Clinical trials (12 756)

Looking for deeper trial context?

Clinical trials (12 756)